Pfizer's stock surges as the pharmaceutical company reports stronger-than-expected earnings, raised profit forecasts, and outlines significant cost-cutting measures to bolster its financial outlook ...

Pfizer reported a jump in second-quarter profits Tuesday behind higher sales of Covid-19 products and some other pharmaceuticals, while also benefiting from lower expenses.

Pfizer raised its full-year profit forecast on Tuesday after topping Wall Street expectations for second-quarter results as ...

Had you invested $1,000 into Pfizer's stock on Aug. 1, 2020, your investment would only be worth around $638 as of Aug. 1, ...

Pfizer (PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Pfizer (NYSE:PFE) stock gains as the company surpasses Q2 2025 expectations with $14.7B revenue and raises its full-year ...

Pfizer (PFE) increased its 2025 profit outlook by 10 cents a share to a range of $2.90 a share to $3.10 a share, citing continued cost cuts, a lower tax rate and "confidence" that strength seen in the ...

COVID questions answered. I just participated in a classic disease spreader: We had a family reunion with over 30 people. One ...

Pfizer hiked its full-year adjusted profit guidance on its cost cuts and strong business performance this year. The company ...

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...

Pfizer Inc. raised its profit forecast for the year with the drugmaker’s ongoing cost cuts helping to make up for a lack of sales growth.

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...